Investigation of the electrochemical properties of ribocycline, a protein kinase inhibitor used in cancer treatment
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
In this thesis, the electrochemical properties of the anti-cancer compound Ribociclib were investigated by a simple, fast and sensitive voltammetric method. The working electrode, boron doped diamond electrode, was activated in anodic direction in 0.5 M H2SO4 medium. On this working electrode, Ribocyciclib gave irreversible waves at about +0.859 V in the oxidation direction and reversible waves around +0.105 V/+0.393 V in the oxidation direction by alternating voltammetry technique in 0.5 M H2SO4 medium. A good correlation between the analytical signal and concentration was obtained at +0.85 V in the concentration range of 1.58-11.06 μM in 0.5 M H2SO4 medium using the square wave voltammetry technique. The applicability of the electroanalytical method developed in this thesis was demonstrated in pharmaceutical drug and urine samples.
Author
Yaşar Aslan
How to Cite
Yaşar Aslan (Master Thesis). Investigation of the electrochemical properties of ribocycline, a protein kinase inhibitor used in cancer treatment, 2024, Batman University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Batman University
- Population book no. 1810 of Cankiri district dated 1246 (1830-1831)(2025)
- The transcription and evaluation of Mardin district's population book registered with the number of 3736(2016)
- The effect of foreign direct investments on carbon dioxide emissions: The example of Turkey(2023)
- The mediating role of emotional well-being in the effect of physical environment quality, food quality, and service quality on revisit ıntention in restaurant businesses(2026)
- Trannscription and evaluation of the muslim population book of Karînâbâd Districk number 6640(2025)
- Diyarbakır center and its surroundings (ditricts) public medicine(2023)
